This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38071728
rdf:type
wikibase:Item
schema:description
article scientifique vetenskaplig artikel מאמר מדעי articolo scientifico artigo científico scientific article published on 03 January 2013 наукова стаття, опублікована в січні 2013 artigo científico videnskabelig artikel artículu científicu espublizáu en 2013 vitenskapelig artikkel scienca artikolo artigo científico wetenschappelijk artikel wissenschaftlicher Artikel научная статья articol științific artikull shkencor vědecký článek vitskapeleg artikkel article científic scientific article published on 03 January 2013 artículo científico مقالة علمية نشرت في 03 يناير 2013 научни чланак scientific article published on 03 January 2013 artikel ilmiah বৈজ্ঞানিক নিবন্ধ vedecký článok bilimsel makale
p:P577
wds:Q38071728-3E38B857-8B89-4947-A17A-650199155C82
wdt:P577
2013-01-03T00:00:00Z
p:P2093
wds:Q38071728-FEFE0CB3-0925-4BF1-B8D9-F47D9A396D41
wdt:P2093
Patrizia Limonta
rdfs:label
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
skos:prefLabel
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
schema:name
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
p:P50
wds:Q38071728-F10EF6D5-7D8F-45A9-90D3-5BAC0E9D7DFB
wdt:P50
wd:Q114260368
p:P1476
wds:Q38071728-3571EA1B-E537-42AC-B1BF-1B8DAD592AD5
wdt:P1476
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
p:P304
wds:Q38071728-2F0FC3B3-5EDB-4EF0-8C26-2B0BE821D8D6
wdt:P304
647-663
p:P31
wds:Q38071728-dbe4cc31-3b6e-426d-8314-f757e28e1d5c wds:Q38071728-AB7AFDE8-3F42-42CB-B478-64A524CDF3D1
wdt:P31
wd:Q7318358 wd:Q13442814
p:P698
wds:Q38071728-93FA2DE5-34B8-476B-AF46-37F6C61BAFE1
wdtn:P698
n10:23290320
wdt:P698
23290320
p:P1433
wds:Q38071728-43E5EF7D-0343-4B3A-B99B-0706B1A8429F
wdt:P1433
wd:Q1955762
p:P433
wds:Q38071728-340505F1-4A12-41AB-AF67-CB442B1E0B81
p:P478
wds:Q38071728-7670376F-6B41-431F-B508-394232D3DE1D
wdt:P433
6
wdt:P478
39
p:P356
wds:Q38071728-7BD2C4D7-A94D-4D94-A96E-A30DA5CC808C
wdtn:P356
n12:J.CTRV.2012.12.003
wdt:P356
10.1016/J.CTRV.2012.12.003